Stem Cell Manufacturing Market Report (2023 to 2031) – Thermo Fisher Scientific, Bio-Rad Laboratories, Becton Dickinson and Company, and Fujifilm Holdings

 | Quelle: Growth Plus Reports Growth Plus Reports

Newark, New Castle, USA, May 12, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the size of the global market for stem cell manufacturing in 2022 to be worth US$ 12.58 billion, and it is expected to increase at a revenue CAGR of 9.3% to reach US$ 27.98 billion by 2031.

The global market for stem cell manufacturing was analyzed and is expected to rise significantly in terms of revenue share during the forecast period. Stem cells have the potential to fundamentally alter medicine and regenerative therapies due to their extraordinary ability to differentiate in a wide variety of specialized cell types. Stem cells can treat various illnesses and ailments and can be obtained from many sources.

Key Takeaways: 

• The rising adoption of regenerative medicine is driving the market revenue share.

• Rising advancements in stem cell production are driving the demand for derived therapeutics.

• Collaboration among top market players is creating a strong product pipeline.

Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/stem-cell-manufacturing-market/8790

                                   Stem Cell Manufacturing Market Scope

Report AttributeDetails
Market Size Value in 2022US$ 12.58 billion
Revenue Forecast in 2031US$ 27.98 billion
CAGR9.3%
Base Year for Estimation2022
Forecast Period2023 to 2031
Historical Year2021
Segments CoveredProduct, Application, End User, and Region
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Recent Development in the Global Stem Cell Manufacturing Market: 

• In January 2022, PeproTech, Inc. (US) was purchased by Thermo Fisher Scientific Inc. for USD 1,850 million in cash. Recombinant proteins are produced and employed in the development of gene therapies as well as other cell culture-related applications.

Competitive Landscape

A list of prominent players operating in the global market for stem cell manufacturing includes: 

  • Lonza Group AG
  • Bio-Rad Laboratories 
  • Becton Dickinson and Company
  • Thermo Fisher Scientific
  • Merck Millipore

Market Drivers and Restraints: 

The global stem cell manufacturing market revenue is driven by increasing demand for regenerative medicine, advancements in stem cell research, increasing government funding, and technological advancements. 

However, due to the several regulatory challenges faced, the market revenue growth is expected to be restrained. 

Request for Customization – https://www.growthplusreports.com/inquiry/customization/stem-cell-manufacturing-market/8790

Market Segmentation: 

Segmentation By Product

Based on the product, the global stem cell manufacturing market is segmented into consumables, instruments, and stem cell lines. Due to the rising demand for stem cell treatments and rising chronic disease prevalence, the stem cell lines segment accounts for the largest market revenue share. 

Segmentation By Application

Based on the application, the global stem cell manufacturing market is segmented into research applications, clinical applications, and cell & tissue banking applications. The clinical application segment accounts for the largest revenue share due to the growing number of stem cell therapy clinical trials and research projects, with promising outcomes in treating problems like cancer, cardiovascular disease, and neurological disorders. 

Regional Growth Dynamics

Based on the region, the global stem cell manufacturing market is segmented into North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa. Due to an established healthcare infrastructure, there are more government initiatives, and there are more investments being made in R&D activities, North America, with the largest revenue share, dominates the global market.

Report Coverage 

Growth Plus Reports studied the global market for stem cell manufacturing in-depth. We studied the fundamental market characteristics, significant investment sectors, regional growth analytics, revenue estimates, competing market players, and mergers and acquisitions.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL STEM CELL MANUFACTURING MARKET - ANALYSIS & FORECAST, BY PRODUCT
    1. Consumables
    2. Instruments
      1. Cell Sorters
      2. Bioreactors and Incubators 
      3. Other Instruments 
    3. Stem Cell Lines 
      1. Mesenchymal Stem Cells (MSC)
      2. Hematopoietic Stem Cells (HSC)
      3. Embryonic Stem Cells (ESC)
      4. Induced Pluripotent Stem Cells (iPSC)
      5. Neural Stem Cells (NSC)
      6. Multipotent Adult Progenitor Stem Cells 
  6. GLOBAL STEM CELL MANUFACTURING MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. Research Application 
      1. Drug Discovery and Development 
      2. Life Science Research 
    2. Clinical Application 
      1. Autologous Stem Cell Therapy 
      2. Allogenic Stem Cell Therapy 
    3. Cell & Tissue Banking Applications 
  7. GLOBAL STEM CELL MANUFACTURING MARKET - ANALYSIS & FORECAST, BY END USER
    1. Research and Academic Institutes 
    2.  Hospitals & Surgical Centers
    3. Cell & Tissue Banks 
    4. Others

STEM CELL MANUFACTURING MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8790

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Eosinophilia Therapeutics Market by Drug Class (Corticosteroids, Immunosuppressant), Type (Blood Eosinophilia, Tissue Eosinophilia), Route of Administration (Oral, Intravenous) – Global Outlook & Forecast 2023-2031

Mortuary Bags Market by Material (PVC, Polyethylene), Size (Adult Bags, Child/Infant Bags), End User (Hospital, Morgue) – Global Outlook & Forecast 2023-2031

Asbestosis Treatment Market by Drug Class (Corticosteroids, Expectorants), Route of Administration (Oral, Inhalation) – Global Outlook & Forecast 2023-2031

Dental Consumables Market by Product (CAD/CAM Devices, Crowns & Bridges, Dental Biomaterials), End User (Hospitals, Dental Clinics) – Global Outlook & Forecast 2023-2031

Viral Vector Production Market by Type (Adenoviral Vectors, Adeno-associated Viral Vectors, Lentiviral Vectors), Disease (Cancer, Genetic Disorders, Infectious Diseases), Application (Gene Therapy, Vaccinology) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020".

 

            








        

            

                

                    
Tags

                            
                                Stem Cell Manufacturing Market
                            

                



        


    

        
Weiterführende Links

        
    



    

        

        
Kontaktdaten